Menu
Explore the growing collection of podcasts talking about all aspects of this often-overlooked disease.
Dave Bammert, RP Foundation President, joined “Full Throttle” host Greg Creamer to talk about 2022. It was an exceptional year for RP-related research, awareness, and education.
David Beck, MD, PhD was one of the NYU Langone Health researchers who identified VEXAS syndrome. He talks about their groundbreaking research and what they’re doing now to find a biomarker for RP.
David Beck, MD, PhD was one of the NYU Langone Health researchers who identified VEXAS syndrome. He talks about their groundbreaking research and what they’re doing now to find a biomarker for RP.
Rashmi Kanagal-Shamanna, MD is a researcher at MD Anderson Cancer Research Center. She discusses the research she’s doing to help identify the link between bone marrow diseases and RP.
Dave is the President of the Relapsing Polychondritis Foundation. He talks about our research initiatives, Race for RP partnership, and the Full Throttle podcast.
Dr. Joseph Ahearn, Chair, Autoimmunity Institute, Allegheny Health Network (AHN), and Michael Linn, Vice-Chair, Relapsing Polychondritis Foundation, discuss RP.
Dr. Stacey Clardy, a neurologist, discusses the signs and symptoms of relapsing polychondritis to better help healthcare professionals diagnose the disease.
Dr. Eoin Flanagan, a neurologist, discusses different tests and results that may be useful in helping diagnose relapsing polychondritis.
Dr. Marcela Ferrada, an infectious disease physician at Johns Hopkins and an RP patient, shares her experience living with RP.
Dr. Marcela Ferrada, an infectious disease physician at Johns Hopkins and an RP patient, discusses RP.
Dr. Marcela Ferrada, an infectious disease physician at Johns Hopkins and an RP patient, discusses her work toward finding a test for RP.
In the coming years, we’ll learn more about Relapsing Polychondritis (RP) and related autoimmune diseases. But we can’t do it without the support of generous individuals and organizations willing to fuel research that will drive breakthroughs. Join us in our race for a cure.